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Two classes of peptide-producing neurons in the arcuate nucleus
(Arc) of the hypothalamus are known to exert opposing actions on
feeding: the anorexigenic neurons that express proopiomelano-
cortin (POMC) and the orexigenic neurons that express agouti-
related protein (AgRP) and neuropeptide Y (NPY). These neurons
are thought to arise from a common embryonic progenitor, but
our anatomical and functional understanding of the interplay of
these two peptidergic systems that contribute to the control of
feeding remains incomplete. The present study uses a combination
of optogenetic stimulation with viral and transgenic approaches,
coupled with neural activity mapping and brain transparency
visualization to demonstrate the following: (i) selective activation
of Arc POMC neurons inhibits food consumption rapidly in unsated
animals; (ii ) activation of Arc neurons arising from POMC-
expressing progenitors, including POMC and a subset of AgRP
neurons, triggers robust feeding behavior, even in the face of
satiety signals from POMC neurons; (iii) the opposing effects on
food intake are associated with distinct neuronal projection and
activation patterns of adult hypothalamic POMC neurons versus
Arc neurons derived from POMC-expressing lineages; and (iv) the
increased food intake following the activation of orexigenic neu-
rons derived from POMC-expressing progenitors engages an ex-
tensive neural network that involves the endogenous opioid
system. Together, these findings shed further light on the dynamic
balance between two peptidergic systems in the moment-to-
moment regulation of feeding behavior.
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Global epidemic obesity underscores the critical need forunderstanding how the brain regulates food intake (1).
Feeding is essential for survival and relies on mechanisms that
monitor energy demands and metabolic status. But feeding be-
havior is more complex, as it has a strong rewarding component
(2) and can respond to environmental stimuli, including stress
and social context (3). Therefore, it is critical to unravel the
mechanisms that modulate both the initiation and the cessation
of feeding.
It is well established that the hypothalamus plays an essential
role in the regulation of feeding behavior and contributes to the
process of energy homeostasis (4, 5). Hypothalamic nuclei en-
gaged in this regulation include the Arc, the paraventricular
nucleus (PVN), the lateral hypothalamic (LH) area, the dorso-
medial nucleus, and the ventromedial nucleus. Disruption of the
ventromedial hypothalamus induces hyperphagia and obesity,
while disruption of the lateral hypothalamus causes hypophagia
and weight loss, suggesting the existence of ventromedial “satiety”
and lateral “feeding” centers (6). Recent work has extended these
early observations and has focused on the Arc of the hypothala-
mus, a nucleus particularly important for the central regulation of
appetite, energy expenditure, and body weight (7, 8).
Two classes of peptide-producing neuronal populations in the
Arc play a central and antagonistic role in the control of appetite—
the orexigenic neurons that express AgRP and NPY promote food
consumption, while anorexigenic neurons that express POMC in-
hibit feeding behavior. AgRP/NPY neurons are active when the
energy stores are not sufficient to meet systemic demands, thereby
releasing AgRP and promoting feeding (9, 10). POMC is a complex
polypeptide precursor cleaved into active peptides including mel-
anocortins and β-endorphin (11). While β-endorphin is a long-
acting opioid analgesic (12), the cosynthesized α-melanocyte stim-
ulating hormone (α-MSH) blocks appetite (13). These two sets of
peptidergic neurons in the Arc respond to nutrient and hormonal
signals from the periphery. Thus, leptin, a signal of positive energy
balance, stimulates POMC neurons, leading to decreased food
intake while inhibiting the release of the orexigenic peptides from
neighboring AgRP/NPY neurons (10). Together, AgRP/NPY neu-
rons and POMC neurons work coordinately to integrate signals of
energy homeostasis and to regulate feeding behavior (8, 14).
Evidence suggests that these two peptidergic systems that
control feeding emerge from a common cellular origin. A de-
velopmental study has demonstrated that embryonic POMC-
expressing progenitors not only give rise to adult POMC cells,
but also differentiate into non-POMC neurons, including NPY
neurons (15). This means transgenic studies that target POMC
cells in early development can capture both adult populations,
whereas adult delivery of viral vectors can target POMC cells
selectively. Consequently, we used optogenetic stimulation re-
lying on both virally mediated and traditional transgenic ap-
proaches to deliver blue light-activated channelrhodopsin 2
(ChR2) to POMC neurons in the Arc. We coupled this stimulation
with behavioral assessments and anatomical analyses examining the
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extent of activation and its consequences on cFos expression
throughout the brain. Thus, we selectively activated neurons
derived from POMC-expressing progenitors in the Arc and
ascertained the net impact on food intake in adult mice. We
contrasted the effect of activating only the POMC neurons ver-
sus the impact of activating both POMC and AgRP/NPY neu-
rons simultaneously on food consumption in mice. Our findings
indicate that selective activation of Arc POMC neurons inhibits
food consumption rapidly in fasted animals whereas activation of
Arc neurons arising from POMC-expressing progenitors results
in a robust increase in food intake. We show that in the conflict
between the drive to consume food and the rapid satiety control
that inhibits feeding, the former dominates, resulting in an acute
increase in feeding. These opposing effects are associated with
distinct projection and activation patterns. Thus, the regulation
of feeding behavior involves a dynamic balance between the two
peptidergic systems.
Results
Characterization of Viral POMC-ChR2 Mice. To control hypothalamic
POMC neurons selectively, we used a Cre-dependent adeno-
associated virus (AAV) vector carrying the gene encoding the
blue light-activated cation channel ChR2 fused to enhanced
yellow fluorescent protein (eYFP). This Cre-inducible double-
floxed inverted ORF (DIO) AAV viral vector AAV5-EF1α-
DIO-ChR2(H134R)-eYFP (Fig. 1A) was microinjected into the
Arc of adult POMC-Cre transgenic mice (16). Upon trans-
duction, Cre-expressing POMC neurons invert the ChR2-eYFP
ORF in irreversible means and ChR2-eYFP proteins are expressed
under control of the elongation factor 1α promoter (referred to
as viral POMC-ChR2). This approach allowed us to selectively
stimulate Arc POMC neurons with blue light (473 nm). We
validated the cell-type selectivity of this viral approach in coronal
Arc sections of viral POMC-ChR2 mice. ChR2-eYFP specifically
colocalized with endogenous POMC neurons (Fig. 1B). On av-
erage, 80% of POMC-positive neurons were positive for ChR2-
eYFP in the virus injection sites (Fig. 1C). Of the ChR2-eYFP
expressing cells, 93% were colocalized by POMC immunostain-
ing (Fig. 1C), demonstrating high specificity of ChR2 expression
in the POMC neurons of the Arc of the viral POMC-ChR2 mice.
To confirm the functional impact of ChR2 activation in the viral
POMC-ChR2 mice, the Arc was illuminated with blue light while
the animal explored an open field chamber. Expression of the
neuronal activity marker, immediate early gene cFos, was evalu-
ated in the Arc of the viral POMC-ChR2 mice with or without
optic stimulation. Activity in the region of virus injection was in-
creased by approximately sevenfold following blue light stimula-
tion [cFos-positive neurons per section: laser off (n = 3 mice),
6.14 ± 1.27; laser on (n = 5 mice), 40.80 ± 3.74; unpaired two-




























































Fig. 1. Characterization of viral POMC-ChR2 mice. (A) Schematic of the Cre-dependent AAV. The ChR2-eYFP gene is doubly flanked by two sets of in-
compatible lox sites. Upon delivery into POMC-Cre transgenic mouse line, ChR2-eYFP is inverted to enable transcription from the EF-1α promoter. (B) Rep-
resentative images showing cell-specific ChR2-eYFP expression (green) in POMC neurons (red) in the Arc of the hypothalamus. (Scale bar, 50 μm.) (C) Statistics
of expression in POMC neurons (n = 6 mice, 894 POMC neurons, 738 ChR2-eYFP neurons). Eighty percent of POMC neurons expressed in ChR2-eYFP neurons;
93% of ChR2-eYFP neurons expressed in POMC neurons. Mean ± SEM. (D) Blue light illumination of the Arc led to induction of cFos (red) in ChR2-eYFP-
positive neurons (green). (Scale bar, 20 μm.) (E) Statistics of cFos-positive neurons in ChR2-eYFP expressing cells at implant region of the Arc with or without
optic stimulation. Six percent of cFos-positive neurons expressed in ChR2-eYFP neurons in the no-optic stimulation group (n = 3 mice, 55 cFos-positive neurons,
410 ChR2-eYFP neurons) versus 77% in light-stimulation group (n = 5 mice, 538 cFos-positive neurons, 554 ChR2-eYFP neurons). Unpaired two-tailed t test:
t(6) = 11.77, ****P < 0.0001. Mean ± SEM.
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colabeled by ChR2-eYFP staining (Fig. 1 D and E). In contrast,
6% of cFos-positive cells were colocalized in ChR2-eYFP staining
in the no-stimulation group (Fig. 1E). These results indicate se-
lective and effective local activation of POMC neurons in the
viral POMC-ChR2 mice.
Characterization of Transgenic POMC-ChR2 Mice. To target ChR2
expression selectively in POMC progenitors, the POMC-Cre
mouse line was crossed to a conditional mouse line containing
Rosa26-CAG-stopflox-ChR2(H134R)-eYFP (17). Offspring of
the double transgenic mouse line are hereafter referred to as
transgenic POMC-ChR2 (Tg POMC-ChR2) (Fig. 2A). Adult Tg
POMC-ChR2 mice exhibited robust expression of ChR2-eYFP
in the Arc (Fig. 2B). We found that both POMC-positive (Fig. 2C)
and AgRP-positive (Fig. 2D) neurons were detected in ChR2-
eYFP expressing cells, indicating that the POMC-expressing line-
age gives rise to two opposing neuronal populations in the Arc
during development. This is consistent with the view that embry-
onic POMC-expressing progenitors differentiate into AgRP/NPY
expressing cells (15). Furthermore, our immunostaining study
revealed that this group of AgRP-positive neurons derived from
POMC-expressing progenitors represents a subset of AgRP neu-
rons in the Arc (Fig. 2D).
Ex vivo, whole-cell current-clamp recording revealed that
ChR2-eYFP-positive cells fired action potentials in response to
repeated light-stimulation patterns used in the hot-plate and
food intake tests of the current study (Fig. 2 E and F), indicating
that ChR2-expressing cells were capable of responding to light
pulses during the entire behavioral testing sessions and they were
well tolerant to light stimulations.
Blue light stimulation of the Arc of Tg POMC-ChR2 mice in-
duced a significant increase in cFos expression in the region below
the implanted optic fiber [cFos-positive neurons per section: laser
off (n = 3 mice), 4.06 ± 0.82; laser on (n = 3 mice), 49.17 ± 1.12;
unpaired two-tailed t test, t(4) = 32.5, P < 0.0001]. Sixty-one
percent of ChR2-eYFP expressing neurons were activated in the
light-stimulation group compared with 5% in the group without
stimulation (Fig. 2G). Using triple-label immunostaining, we
found that both POMC-positive and AgRP-positive neurons (Fig.
2 H and I) were activated by light stimulation as assessed by in-
duction of the cFos. These results demonstrate that, in adult Tg
POMC-ChR2 mice, ChR2 proteins are expressed in POMC or
AgRP neurons and these two opposing neuronal populations are
simultaneously activated by light stimulation.
Rapid Inhibition of Feeding Behavior in Fasted Viral POMC-ChR2 Mice.
We first examined whether activating POMC neurons by opto-
genetic stimulation was sufficient to reduce food intake in viral
POMC-ChR2 mice. Food consumption was measured for 30 min
each day for three consecutive days (day 1, blue laser off; day 2,
blue laser on; day 3, blue laser off). Mice were food-deprived for
4 h each day before the food intake test. The laser stimulation
parameters used on day 2 were 15-ms light pulses at 10 Hz for
30 s every minute for 30 min. Stimulation of Arc POMC neurons
in fasted viral POMC-ChR2 mice resulted in a significant re-
duction in food intake (Fig. 3A). In addition, we studied the
impact on pain regulation since this is one of the most classical
and well-established effects of β-endorphin (18). The latency for
the mice to lick their paws was measured in the hot-plate test.
Viral POMC-ChR2 mice showed an increased nociceptive
threshold following light stimulation (Fig. 3B). This analgesic
effect induced by light stimulation could be blocked by pre-
treatment with the opioid antagonist naloxone (Fig. 3C), sug-
gesting that β-endorphin was released by activation of Arc
POMC neurons. Together, these results demonstrate that func-
tional neuropeptides in POMC neurons can be released by light
stimulation, and activation of Arc POMC neurons leads to acute
inhibition of food intake in fasted animals.
Rapid and Robust Increase in Food Intake in Tg POMC-ChR2 Mice. In
Tg POMC-ChR2 mice, ChR2 protein was expressed in neurons
derived from POMC-expressing progenitors in the Arc including
POMC- and AgRP-positive neurons. We also demonstrated that
both POMC and AgRP neurons are simultaneously activated by
light stimulation in the Arc of Tg POMC-ChR2 mice. Hot-plate
and food intake tests were performed in this double transgenic
mouse line. Activation of the Arc in Tg POMC-ChR2 mice by
light stimulation induced an acute analgesic effect in the hot-
plate test (Fig. 4A), which could be blocked by pretreatment with
naloxone (Fig. 4B). This suggests that POMC neurons in the Tg
POMC-ChR2 mice are functionally activated by optogenetic
stimulation. Latency for single transgenic littermate control mice
without ChR2-eYFP expression to lick their paws was unchanged
following optogenetic stimulation (Fig. 4A). Surprisingly, Tg
POMC-ChR2 mice displayed a vigorous increase in food intake
in response to light stimulation in the Arc (Fig. 4C). There was
no change in food consumption in control mice following pho-
tostimulation (Fig. 4C). These results demonstrate that activa-
tion of the Arc in Tg POMC-ChR2 mice leads to a dramatic
increase in food intake, counteracting the effect of activation of
POMC neurons in the same area. Thus, the orexigenic neurons
that drive food consumption clearly override the anorexigenic
neurons that inhibit feeding in this animal model.
Distinct Neuronal Projections Between Viral and Tg POMC-ChR2 Mice
Visualized via 3D Imaging. A number of recently developed brain
transparency techniques permit the 3D visualization of fluorescent-
labeled molecules in genetically modified animals. The CLARITY
(19–21) and iDISCO (22) methods are two such approaches
capable of illuminating neuronal networks that may offer in-
sight into brain connectivity in large millimeter-thick tissue
samples. To better understand the potential association be-
tween behavior phenotypes and related brain circuitries, we
implemented the CLARITY and iDISCO methods for the viral
and Tg POMC-ChR2 animal brain samples, respectively. In
the viral POMC-ChR2 mice, anti-GFP antibody-labeled fibers
originating from the Arc were observed throughout the extent
of analyzed samples (Fig. 5 A and B and Movies S1 and S2).
Our findings show that the Arc POMC neurons send efferent
projections to various regions, including: (i) ventral to the
median eminence; (ii) rostral to the medial preoptic nuclei, the
bed nucleus of the stria terminalis, the nucleus accumbens
(NAcc), the lateral and medial septum, and lateral habenular
nucleus; (iii) dorsal to the thalamic periventricular nucleus; (iv)
lateral to the amygdala; (v) caudal to the brainstem regions, in-
cluding the periaqueductal gray; and (vi) ventrocaudal to the
mammillary nucleus (SI Appendix, Table S1). Arc POMC neurons
project extensively to paraventricular, dorsomedial, and lateral
hypothalamic nuclei. Additionally, anterior and periventricular
hypothalamic areas and zona incerta also receive direct and
dense inputs from the Arc. Nucleus of the vertical limb of the
diagonal and the horizontal limb of the diagonal band also re-
ceive direct projections from the Arc POMC neurons (SI Ap-
pendix, Table S1).
In contrast, in neurons derived from POMC-expressing pro-
genitors in the Arc of the Tg POMC-ChR2 mice, the majority of
their projections remain within hypothalamic areas (Fig. 6 A and
B and Movies S3 and S4). Here, anti-GFP antibody-labeled fi-
bers were observed terminating in the paraventricular, periven-
tricular, anterior, and the dorsomedial hypothalamus. It is
remarkable that the most qualitatively robust innervation was
seen within the lateral hypothalamic nucleus (Fig. 6 A and B and
Movies S3 and S4). We also observed the anti-GFP antibody-
labeled signals in the dentate gyrus of the hippocampus (Fig. 6A)
in Tg POMC-ChR2 mice. This is not surprising, given that ex-
pression of POMC follows a dynamic pattern during develop-
ment and POMC expression in some regions of an embryo is
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Fig. 2. Characterization of Tg POMC-ChR2 mice. (A) Genetic design for ChR2-eYFP expression in the Arc. (B) Expression of ChR2-eYFP in the Arc. (C) Rep-
resentative images showing colocalization of POMC-positive neurons with ChR2-eYFP expressing cells in the Arc. Inset shows ChR2-eYFP expression (green) in
POMC neurons (red). (Scale bar, 50 μm.) (Scale bar in Inset, 20 μm.) (D) Representative images showing colocalization of AgRP-positive neurons with ChR2-
eYFP expressing cells in the Arc. Inset shows ChR2-eYFP expression (green) in a subgroup of AgRP neurons (red). Yellow arrows point to ChR2-eYFP-positive
AgRP neurons; white arrows point to ChR2-eYFP-negative AgRP neurons. (Scale bar, 50 μm.) (Scale bar in Inset, 20 μm.) (E and F) Representative whole-cell
current-clamp recordings of ChR2-eYFP-positive neurons in the Arc from acute slices. To replicate the stimulation pattern used in the hot-plate test, the
neuron was stimulated with 15-ms light pulses at 10 Hz for 6 min (indicated by blue bar). After the 6-min period of action potential firing, the light was turned
off to show the specificity of the response to light stimulation. Action potential firing resumed at 10 Hz when the light in turned back on. Insets show in-
dividual action potential firing at 10 Hz at the times indicated by the numbers. To replicate the stimulation pattern used in the food intake study, the neuron
was stimulated with 15-ms light pulses at 10 Hz for 30 s (indicated by blue bar) every other 30 s for 30 min. For simplicity, only the first stimulation period
(during minute 1; Left trace) and the last stimulation period (during minute 30; Right trace) are shown. Insets show individual action potential firing at 10 Hz
at the times indicated by the numbers. n = 25 cells, 15 slices from 8 mice. (G) Statistics of cFos-positive neurons in ChR2-eYFP expressing cells in the region
below the implanted optic fiber in the Arc with or without optic stimulation. Five percent of cFos-positive neurons expressed in ChR2-eYFP neurons in the no-
optic stimulation group (n = 3 mice, 30 cFos-positive neurons, 522 ChR2-eYFP neurons) versus 61% in the light-stimulation group (n = 3 mice, 543 cFos-positive
neurons, 901 ChR2-eYFP neurons). Unpaired two-tailed t test: t(4) = 13.63, ***P < 0.001. Mean ± SEM. (H) Representative images showing the induction of
cFos (white) in POMC-positive (red) ChR2-eYFP expressing neurons (green) (yellow arrows) following blue light stimulation in the Arc. POMC-positive neurons
were immunostained with anti–β-endorphin antibody. (Scale bar, 20 μm.) (I) Representative images showing the induction of cFos (white) in AgRP-positive
(red) ChR2-expressing neurons (green) (yellow arrows) following light stimulation in the Arc. (Scale bar, 20 μm.)
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transient (23), including the granule cells of the dentate gyrus
(24). These results demonstrate distinct neuronal projection
patterns in these two animal models.
Distinct Neuronal Activation Patterns Between Viral and Tg POMC-
ChR2 Mice. Given the opposite effects on food intake between
viral POMC-ChR2 and Tg POMC-ChR2 mice, we evaluated the
neuronal activation as determined by cFos mRNA expression
following light stimulation in the Arc in these two animal models.
Activation of POMC neurons of the Arc in viral POMC-
ChR2 mice led to an increase in cFos in limited brain regions
(Fig. 5C), including cerebral cortex, lateral septum, PVN, dor-
somedial hypothalamus, Arc, and the medial posterior part of
the Arc (SI Appendix, Table S2). In contrast, activation of the
Arc in Tg POMC-ChR2 mice resulted in an intensive cFos re-
sponse in broader areas of the brain (Fig. 6C), including cerebral
cortex, prefrontal cortex (PFC), caudate-putamen (CPu), NAcc,
septum, lateral thalamus, PVN, LH, dorsomedial hypothalamus,
and Arc (SI Appendix, Table S3). These results suggest that this
acute increase in food intake following activation of the Arc in
Tg POMC-ChR2 mice engages an extensive neuronal system in
the brain.
Role of Endogenous Opioids in Increased Feeding in Tg POMC-ChR2
Mice. We further investigated the role of endogenous opioids in
increased food intake observed in Tg POMC-ChR2 mice. This
increased feeding could be largely blocked by pretreatment with
naloxone in a dose-dependent manner (Fig. 7A), indicating the
driving force to consume food can be partially abolished by
blocking opioid receptor signaling in this animal model. Fol-
lowing naloxone pretreatment, increased cFos mRNA expression
in LH, dorsomedial hypothalamus, and the Arc was observed in
response to light stimulation in the Arc of the Tg POMC-
ChR2 mice (Fig. 7B and SI Appendix, Table S4). It should be
noted that the induction of neuronal activity in the Arc and LH
was reduced by 63% and 52%, respectively, following naloxone
pretreatment (Arc: optical density of cFos induction 0.74 versus













































































Fig. 4. Activation of Arc neurons derived from POMC-expressing lineage increases food intake in Tg POMC-ChR2 mice. (A) Repeated-measures two-way
ANOVA revealed a significant genotype × day interaction, F(2, 82) = 9.44, P < 0.001, for the hot-plate test. Blue light stimulation of Arc neurons in Tg POMC-
ChR2 mice led to an increased latency for the animals to lick their paws, F(2, 52) = 21.91, P < 0.0001; ****P < 0.0001; n = 27 mice. Latency for single transgenic
littermate control mice without ChR2-eYFP expression to lick their paws was unchanged, F(2, 30) = 1.06, P = 0.36; n = 16 mice, 8 mice per single transgenic
mouse line. (B) Increased latency induced by light stimulation in Tg POMC-ChR2 mice was reduced by pretreatment with opioid antagonist naloxone,
F(2, 24) = 15.2, P < 0.0001; ***P < 0.001, ****P < 0.0001; n = 13 mice. (C) Repeated-measures two-way ANOVA revealed a significant genotype × day interaction,
F(2, 54) = 76.59, P < 0.0001, for the food intake study. Light stimulation of Arc neurons evoked a robust increase in food intake in Tg POMC-ChR2 mice,
F(2, 24) = 68.28, P < 0.0001; ****P < 0.0001; n = 13 mice. Food intake for control mice was unchanged following light stimulation of Arc, F(2, 30) = 1.19, P = 0.32;








































































Fig. 3. Selective activation of POMC neurons in the Arc suppresses food intake in fasted viral POMC-ChR2 mice. (A) Blue light stimulation of POMC neurons
induced a reduction of food intake in 4-h fasted viral POMC-ChR2 mice, F(2, 40) = 18.99, P < 0.0001; ****P < 0.0001; n = 21 mice. (B) Light stimulation of POMC
neurons led to an increased latency for the mice to lick their paws during the hot-plate test, F(2, 30) = 8.82, P < 0.01; **P < 0.01; n = 16 mice. (C) Increased
latency induced by light stimulation was blunted by pretreatment with opioid antagonist naloxone (10 mg/kg) in the hot-plate test, F(2, 28) = 6.797, P < 0.01;
*P < 0.05; **P < 0.01; n = 15 mice. Repeated-measures one-way ANOVA followed by Turkey’s test were used for all above statistics. Box plots show median,
mean (+), lower and upper quartiles (boxes), and minima and maxima (whiskers).








induction 0.21 versus 0.10 relative to respective control) (SI
Appendix, Tables S3 and S4). Equally important, the cFos re-
sponse in most brain regions was completely abolished by pre-
treatment with naloxone (Fig. 7B and SI Appendix, Table S4),
including cerebral cortex, PFC, CPu, NAcc, septum, PVN, and
lateral thalamus. These results suggest that the acute increase in
food intake following activation of the Arc in Tg POMC-ChR2 mice
is likely mediated by activation of the opioid receptor-signaling sys-











Fig. 5. Anatomical analysis of Arc POMC neuronal projections and the extent of
activation in viral POMC-ChR2 mice. (A) eYFP-expressing Arc POMC neurons and
their connectivity shown as a max intensity z-projection image. Representative
CLARITY processed image shows prominent arcuate connectivity with the para-
ventricular, dorsomedial, and lateral hypothalamus, as well as the zona incerta,
periaqueductal gray, and lateral septum in the viral POMC-ChR2mouse brain slice
(4-mm thickness). (Scale bar, 1500 μm.) (B) Magnified view shows a more detailed
eYFP expression pattern in the Arc in the viral-injected hemisphere. (Scale bar,
600 μm.) (C) Neuronal activation in the brain following light stimulation in the
Arc of viral POMC-ChR2 mice. ISH revealed cFos mRNA expression was increased
in limited brain regions in response to selective activation of Arc POMC neurons.
Images were quantitatively analyzed with results shown in SI Appendix, Table S2.
Representative images are shown ranging from Bregma 1.10 mm (indicated by
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Fig. 6. Anatomical analysis of the projections of Arc neurons derived from
POMC-expressing progenitors and the extent of activation in Tg POMC-ChR2mice.
(A) Labeled Arc neurons and their connectivity shown as a max intensity z-
projection image. Representative image shows prominent arcuate connectivity
with the dorsomedial, paraventricular, and lateral hypothalamus in the Tg POMC-
ChR2mouse brain slice (2-mm thickness) processed with the iDISCOmethod. (Scale
bar, 1000 μm.) (B) Magnified view shows detailed eYFP expression pattern in the
Arc. (Scale bar, 500 μm.) (C) ISH revealed cFos mRNA expression was intensively
increased in broader brain areas in response to activation of Arc neurons of Tg
POMC-ChR2 mice. Images were quantified with results shown in SI Appendix,
Table S3. Representative images are shown ranging from Bregma 1.10 mm (in-
dicated by the no. 1) through Bregma −2.12 mm (indicated by the no. 8).
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Discussion
In this study, we examined the relationship between cell-type–
specific neuron activation and feeding behavior by optogenetic
stimulation of both mature POMC neurons and neurons derived
from POMC-expressing progenitors in the Arc of the hypothal-
amus. This body of work revealed the following main findings: (i)
selective activation of POMC neurons rapidly inhibits feeding in
food restricted animals; (ii) simultaneous activation of both
POMC and orexigenic neurons derived from a common pro-
genitor, including a subset of AgRP neurons, leads to a robust
increase in feeding; (iii) 3D imaging delineates the projection
pattern of adult hypothalamic POMC neurons versus the pro-
jection pattern of neurons derived from embryonic POMC-
expressing cells that differentiate into POMC and a subset of
the AgRP population; (iv) brain regions induced by activation of
POMC alone and associated with reduced feeding include the
cerebral cortex, lateral septum, PVN, dorsomedial hypothala-
mus, and the Arc; (v) coupling of neuronal activation and
pharmacological treatment shows that activation of orexigenic
neurons derived from POMC-expressing progenitors engages an
extensive neural network that involves the endogenous opioid
system. Thus, the increased food intake was blunted by pre-
treatment with naloxone, an opioid receptor antagonist. This was
accompanied by the normalization of neural activity in most of
the activated brain regions, including the cerebral cortex, PFC,
CPu, NAcc, septum, PVN, and lateral thalamus.
In the Arc, posttranslational processing of the POMC pro-
hormone results in two primary peptide products, α-MSH and
β-endorphin (11). β-Endorphin is involved in pain regulation
(12) and α-MSH mediates the anorexigenic effect on feeding (7,
25–29). In this study, both viral POMC-ChR2 and Tg POMC-
ChR2 mice showed an analgesic effect induced by light stimu-
lation, demonstrating functional activation of POMC neurons in
these two animal models. Selective stimulation of POMC neu-
rons in viral POMC-ChR2 mice led to decreased food intake,
consistent with the observation that the hypothalamic melano-
cortin pathway is involved in feeding behavior (9, 10). This acute
inhibition of feeding in fasted viral POMC-ChR2 mice is also
consistent with pharmacological studies (25–29). Thus, an α-MSH
agonist has a potent inhibitory effect on deprivation-induced food
intake within 1 or 2 h (28, 29) when administrated in the PVN,
a site that receives projections from Arc POMC neurons and
where MC4-R expression is very high. However, our finding is in
partial contrast with previous studies using optogenetic (30) or
chemogenetic (31, 32) activation of POMC neurons. While these
studies demonstrate reduced food consumption, they report that
the effect is not evident until 24 h of stimulation in ad libitum-fed
mice (30–32). One possibility for this discrepancy is that we used
a different light-stimulation pattern in our study. Another dif-
ference is that our mice were fasted for 4 h, which may con-
tribute to the more immediate effects of stimulation on feeding
behavior. Our results suggest that Arc POMC neurons exert
faster regulation of satiety in food-motivated mice. This finding
is supported by a recent report that at least some Arc POMC
neurons may act on faster time scales to reduce the drive to seek
food (33). The combination of these pharmacological and opto-
or chemogenetic studies would lead to a more complex view of
the role of POMC in food regulation, whereby it would exert a
long-term modulatory role based on metabolic status in the
freely feeding animals, but is also active on shorter time scales
during times when the animal is motivated to eat and the mon-
itoring of food intake by these appetitive circuits is more critical.
This does not preclude other mechanisms that recruit POMC to
induce eating cessation (31, 32).
Surprisingly, in Tg POMC-ChR2 mice, activation of Arc
neurons derived from POMC-expressing progenitors evoked
voracious feeding. We have demonstrated that in these animals,
ChR2 is expressed in both POMC- and AgRP-positive neurons,
and these two groups of neurons are simultaneously activated as
determined by cFos protein induction. The POMC neurons in
the Arc were also functionally activated as evidenced by the pain
regulation experiment in this animal model. The increased food
intake in Tg POMC-ChR2 mice demonstrates that activation of
this subset group of orexigenic neurons derived from POMC-
expressing progenitors overrides the anorexigenic effect con-
tributed by POMC neuron activation. It is well established that
POMC and AgRP/NPY neurons in the Arc exert opposing ac-
tions on feeding to maintain energy homeostasis in the body (8,
14). Genetic and pharmacological evidence suggests that AgRP/
NPY neurons promote feeding and increase body weight (8–10).
Opto- or chemogenetic stimulation of AgRP neurons promotes




































Fig. 7. Involvement of endogenous opioids in the increased feeding of Tg
POMC-ChR2 mice. (A) Increased food intake in Tg POMC-ChR2 was reduced
by pretreatment with naloxone in a dose-dependent manner (n = 6 mice in
2 mg/kg naloxone group; n = 8 mice in 10 mg/kg naloxone group). A mul-
tilevel regression model was used to assess the effects of light stimulation,
naloxone treatment, and naloxone dosage on food intake, as well as a
conditional effect of dosage on naloxone treatment (naloxone × dosage).
Light stimulation increased food intake, β = 1.08, T(25) = 12.26, P < 0.0001, in
a manner that was opposed by naloxone treatment at 2 mg/kg, β = −0.33,
T(25) = −2.61, *P < 0.05. The ability of naloxone to oppose the effects of
the light stimulation was even stronger in the group of mice treated with a
higher dosage of naloxone, β = −0.42, T(25) = −2.71, *P < 0.05; 10 mg/kg
versus 2 mg/kg. Otherwise food intake in these two groups of mice was
similar, β = 0.04, T(12) = 0.27, P = 0.79. Mean ± SEM, 2 mg/kg naloxone
group: 0.13 ± 0.02 (light off, saline); 1.13 ± 0.23 (light on, saline); 0.84 ± 0.18
(light on, naloxone); 10 mg/kg naloxone group: 0.092 ± 0.024 (light off,
saline); 1.24 ± 0.11 (light on, saline); 0.46 ± 0.069 (light on, naloxone). (B) ISH
revealed that cFos mRNA expression was either normalized or reduced in
brain regions involved in reward and motivation by pretreatment with
opioid antagonist naloxone (10 mg/kg). Images were quantified with results
shown in SI Appendix, Table S4. Representative images are shown ranging
from Bregma 1.10 mm (indicated by the no. 1) through Bregma −2.12 mm
(indicated by the no. 8).








food consumption following optogenetic activation in the
transgenic and the viral models and their differences in potency
stand in sharp contrast to the effects on analgesia. Thus, opto-
genetic stimulation in both the viral and the transgenic models
produced comparable analgesic potency. This is likely because,
in both cases, the analgesia is elicited from the activation of
POMC neurons only, whereas the food regulation is the result of
the relative power of POMC versus AgRP/NPY neurons. Taken
together, our finding of increased food intake in Tg POMC-
ChR2 mice suggests that mechanisms that increase satiety may
not be as effective under conditions that enhance the inhibition
of food consumption and oppose AgRP.
The increased food intake in Tg POMC-ChR2 mice can be
largely blocked by pretreatment with the nonselective opioid
receptor antagonist naloxone, suggesting involvement of the
opioid receptor-signaling system. Other neural systems may also
contribute to this increased food intake because naloxone did
not completely block the increased food intake. Opioids are a
family of peptides that differentially interact with three receptor
classes (37). Anatomical studies have demonstrated that opioid
receptors and peptides are widely distributed throughout the
brain (38), including in a number of hypothalamic nuclei. Given
the wide distribution of opioid receptors and the presence of
other neuropeptides in the vicinity of opioidergic pathways,
opioids are in position to affect many aspects of feeding and
energy homeostasis (39, 40). Pharmacological studies have in-
dicated that opioids stimulate food intake, whereas opioid an-
tagonists are inhibitory (39, 40). It should be noted that this
increased food intake in Tg POMC-ChR2 mice may not be solely
due to the release of endogenous β-endorphin. Selective acti-
vation of POMC neurons in unsated viral POMC-ChR2 mice
induced a reduction of food intake despite the possibility that
endogenous β-endorphin was likely released as evidenced by an
analgesic effect during the hot-plate test.
We then investigated the possible neural mechanisms whereby
activation of Arc neurons derived from POMC-expressing pro-
genitors led to increased food intake while selective activation of
POMC neurons resulted in decreased food intake using cFos
mRNA as a marker. Selective activation of POMC neurons in
viral POMC-ChR2 mice led to neural activation in limited brain
regions that are typically thought of as regulating food intake
(41), including cerebral cortex, lateral septum, PVN, dorsome-
dial hypothalamus, and Arc. Classic lesion studies in PVN,
dorsomedial, or ventromedial hypothalamus induced hyperpha-
gia and obesity, while electrical stimulation increased food intake
(6). In addition, we found increased neural activity in cerebral
cortex and lateral septum following stimulation of Arc POMC
neurons, indicating their possible involvement in regulating
food intake.
In contrast, activation of the Arc in Tg POMC-ChR2 mice
resulted in an intensive cFos response in broader areas of the
brain thought to modulate feeding behavior (8, 42–44), including
cerebral cortex, PFC, NAcc, septum, PVN, LH, and dorsomedial
hypothalamus. More importantly, the neuronal activity in cere-
bral cortex, PFC, CPu, NAcc, septum, and PVN was normalized
by pretreatment with naloxone, while the neuronal activity of the
LH was reduced by 52% with the same pretreatment. Several of
these responsive regions, such as the PFC, the NAcc, and the
LH, have connections with reward systems and motivated be-
havior that modulate feeding (42–44). For example, activation of
dopamine D1 receptor-expressing neurons in the PFC increases
food intake (45). The NAcc functions as a major projection area
for food reward and motivation in the mesolimbic dopaminergic
system (42). The LH is known to be a critical neuroanatomical
substrate for motivated feeding behavior in corticostriatal–
hypothalamic circuitry (43). Thus, the activation of the subset of
orexigenic neurons derived from POMC-expressing progenitors
in Tg POMC-ChR2 mice may influence the rewarding charac-
teristics of food and/or the motivational component of feeding.
We also investigated the architecture of neural circuits spe-
cifically originating from Arc peptidergic neurons on a brain-
wide scale in these two animal models via 3D visualization. In the
viral POMC-ChR2 mice, CLARITY processing showed that Arc
POMC neurons project to a number of brain regions (SI Ap-
pendix, Table S1), consistent with previous anatomical studies
(46, 47). Our detailed mapping of Arc POMC neuronal con-
nectivity points to functional studies on the roles and circuit
mechanisms underlying the regulation of feeding in these areas.
The apparent diffuse projections of Arc POMC terminals ob-
served suggest that POMC participates in the regulation of food
consumption not only through hypothalamic structures, but also
extrahypothalamic nuclei, including the amygdala, zona incerta,
and lateral septum. More specifically, the amygdala is of interest
as it is an area implicated in emotional aspects of feeding be-
havior. Recent studies have also shown that activation of zona
incerta GABAergic neurons results in rapid binge-like eating
behavior (48), while inactivation of lateral septum neurons
blunts ventral hippocampus-induced suppression of feeding (49).
However, it is still not fully understood how the inputs from Arc
POMC neurons affect the neuronal physiology in these brain
regions or their potential regulation of feeding behavior. In
contrast to the viral POMC-ChR2 mice, a seemingly greater
intensity of hypothalamic eYFP signal in the Tg POMC-ChR2
mice necessitated diminishing the comparatively less intense
extrahypothalamic projections through the image threshold
function. Nevertheless, the 3D visualization of neuronal projec-
tions in Tg POMC-ChR2 mice highlights the extensive neuronal
communication between the Arc and lateral hypothalamic nu-
cleus which is at the center of feeding control.
In sum, the POMC-expressing progenitors in the Arc differ-
entiate into two functionally distinct neuronal subpopulations to
influence feeding behavior in adulthood. Furthermore, the dif-
ferences in food intake are associated with distinct projection
and activation patterns of Arc neurons derived from POMC-
expressing lineages compared with adult hypothalamic POMC
neurons. Translational applications that aim to control appetite
likely need to target the activation rather than the inhibition
mechanisms and to modulate either the AgRP system itself or its
downstream mediators. The fact that increased food intake in Tg
POMC-ChR2 mice can be blunted by the opioid antagonist
naloxone coupled with the normalization of neuronal activity in
brain regions involved in reward and motivation highlights the
potential value of targeting opioid receptor signaling to control
feeding behavior.
Materials and Methods
Animals. POMC-Cre and Rosa26-CAG-stopflox-ChR2(H134R)-eYFP (Ai32) mice
were generated as previously described (16, 17). All experiments were con-
ducted in accordance with the principles and procedures outlined in the
National Institutes of Health Guidelines for the Care and Use of Animals and
were approved by the Institutional Animal Care and Use Committee at the
University of Michigan. More detailed information is provided in SI Ap-
pendix, SI Material and Methods.
Stereotactic Surgery and Virus Vector Injection. For the Tg POMC-ChR2 mice,
optical fiber was unilaterally placed above the right Arc [coordinates,
Bregma: (anterior–posterior, AP) −1.62 mm, (dorso–ventral, DV) 5.60 mm,
(medio– lateral, ML) 0.33 mm]. For the POMC-Cre mice, Cre-dependent
double-floxed deno-associated virus AAV5-EF1α-DIO-ChR2(H134R)-eYFP (50)
was injected unilaterally in the right Arc [coordinates, Bregma: (AP)
−1.62 mm, (DV) 5.70 mm, (ML) 0.30 mm]. Following injection, optical fiber
was implanted over the Arc [(AP) −1.62 mm, (DV) 5.45 mm, (ML) 0.30 mm].
This mouse line of POMC-Cre with selectively expression of ChR2 in adult-
hood by viral-mediated method is referred to as viral POMC-ChR2. For de-
tails see SI Appendix, SI Material and Methods.
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Slice Electrophysiology. For whole-cell current-clamp recordings, ChR2-eYFP-
positive neurons in the Arc from acute slices were stimulated with repeated
light-stimulation patterns used in the hot-plate and food intake tests of the
current study. For details see SI Appendix, SI Material and Methods.
Immunohistochemistry. Staining of brain sections from viral POMC-ChR2 and
Tg POMC-ChR2 mice with anti-GFP, anti-POMC, anti-AgRP, anti–β-endorphin,
and anti-cFos was done as described in SI Appendix, SI Material and Meth-
ods. For all cFos protein induction experiments, mice received 6 min of blue
laser (473 nm) stimulation (10 Hz, 15-ms pulses, 4.3 mW on the tip of fiber) in
the open field chamber, then returned to their home cage. Animals were
perfused 90 min after the onset of light stimulation. For details see SI Ap-
pendix, SI Material and Methods.
Behavioral Experiments. All behavioral tests were conducted at least 3-wk
postsurgery during the same circadian period (0900–1600). Mice were han-
dled and attached to the optical fiber without photostimulation for 4 d
before behavioral tests. For the hot-plate test, the latency (in seconds) for
the mice to lick their paws was measured (cutoff time, 60 s). On 3 consecu-
tive testing days, mice were connected to the optical fiber and placed in an
empty mouse cage for 5 min (day 1, blue laser off; day 2, blue laser on; day 3,
blue laser off). Immediately following this 5-min period, mice were then
tested on the hot plate. Blue laser stimulation (15-ms pulses, 10 Hz, 4.3 mW
on the tip of fiber) on day 2 continued until the completion of the test. For
naloxone pretreatment studies, mice were injected intraperitoneally with
saline or naloxone HCl (10 mg/kg) 15 min before laser stimulation.
For the regular food intake test, mice had ad libitum access to standard
laboratory pellet food in the home cage before and after tests. Each mouse
was tested at the same time each day. Food consumption was measured for
30 min for 3 consecutive days (day 1, laser off; day 2, blue laser on; day 3, blue
laser off). The laser stimulation parameters used on day 2 were 15-ms light
pulses at 10 Hz for 30 s every minute for 30 min with 4.3 mW light power on
the tip of fiber. For naloxone pretreatment in the Tg POMC-ChR2 mouse line,
animals were injected intraperitoneally with saline or naloxone (2 mg/kg;
10 mg/kg) 15 min before laser stimulation. For the food intake test in viral
POMC-ChR2 mice, animals were food deprived for 4 h with water freely
available before the regular food intake test each day. The laser stimulation
on day 2 was the same as described above. More detailed information is
provided in SI Appendix, SI Material and Methods.
Three-Dimensional Visualization. For 3D imaging of immunofluorescence in
viral POMC-ChR2 mice, the CLARITY procedure (19–21) was followed (SI
Appendix, SI Material and Methods). For 3D imaging of immunofluores-
cence in Tg POMC-ChR2 mice, the iDISCO method (22) was followed (SI
Appendix, SI Material and Methods). CLARITY optimized light sheet micro-
scope (COLM) was used to acquire the images (20). Tiles of acquired image
stacks were stitched together using TeraStitcher and subsequently visualized
in 2D through orthoslice mode and in 3D through maximum intensity pro-
jection volume rendering mode using Amira 3D software.
cFos mRNA Expression Following Optogenetic Stimulation. For all cFos mRNA
response experiments, mice received 6 min of either blue laser stimulation
(10 Hz, 15-ms pulses, 4.3 mW on the tip of fiber) or no laser stimulation in the
open field chamber, and then were returned to their home cage. Mice were
killed by rapid decapitation 30 min after the onset of laser stimulation and
their brains were dissected. For naloxone pretreatment in the Tg POMC-
ChR2 mouse line, animals were injected intraperitoneally with naloxone
(10 mg/kg) 15 min before laser stimulation. In situ hybridization (ISH)
methodology was performed as previously described (51). For details see SI
Appendix, SI Material and Methods.
Statistical Analysis. Statistical analyses were performed using Prism 7.0
(GraphPad) software or R software. P < 0.05 was considered statistically
significant. Experimental animals demonstrating inaccurate viral injection or
cannula sites were excluded from the present study since these subjects
lacked expression of the reporter gene or neuronal activity marker cFos.
These validation parameters were established before data analysis. For the
naloxone pretreatment study on feeding behavior in Tg POMC-ChR2 mice,
a multilevel regression model (also known as a hierarchical linear model or
a mixed-effects model) was used to assess the effects of light, naloxone
treatment, and naloxone dosage on food intake, while accounting for
within-subjects design. These analyses were performed in R (R v.3.3.0: https://
cran.r-project.org; RStudio v.0.99.896: www.rstudio.com/) using the lme()
function in the nlme package (https://CRAN.R-project.org/package=nlme)
with a default correlation structure (no within-group correlation) and
method (restricted maximum likelihood). Our model included the fixed ef-
fects of the factors light (reference level = off), naloxone treatment (refer-
ence level = no naloxone), and dosage (reference level = 2 mg/kg), as well as
a conditional effect of dosage on naloxone treatment (naloxone × dosage),
with repeated measures accounted for by including individual subjects as a
random effects variable (random intercept).
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